InsightfulValue
← Home

Novo Nordisk
Novo Nordisk

Pharma / Pharmaceuticals and Healthcare


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

Novo Nordisk

πŸ“Š Get full analytics about Novo Nordisk

Sign up for free or log in

πŸ”“ Unlock our free guide: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

Price
Live  
Overview
Novo Nordisk is a global healthcare company specializing in the development, manufacture, and distribution of pharmaceutical products and medical devices. It was founded in Denmark in 1923 and has since expanded to become one of the largest and most well-known companies in the healthcare industry.
The company's main focus is on developing treatments for diabetes, obesity, and other serious chronic conditions. It is also involved in the production of insulin, which is a hormone used to regulate blood sugar levels in people with diabetes.
Novo Nordisk operates in more than 80 countries worldwide and employs over 45,000 people. It has research and development facilities in several countries, including Denmark, the United States, China, and India.
The company is committed to making a positive impact on society and follows a triple bottom line approach, incorporating social, environmental, and financial considerations into its business strategy. This includes a focus on sustainable environmental practices, ethical business conduct, and community engagement.
Novo Nordisk is also recognized for its strong corporate social responsibility efforts, including partnerships with organizations such as the World Diabetes Foundation and the International Diabetes Federation. It has also received recognition for its commitment to diversity and inclusion in the workplace.
In addition to its primary focus on diabetes and obesity, Novo Nordisk has expanded its portfolio to include products for the treatment of rare blood and endocrine disorders and growth disorders. It has also recently entered the field of cardiovascular disease and chronic kidney disease.
Overall, Novo Nordisk continues to be a leader in the healthcare industry, dedicated to improving the lives of patients and making a positive impact on global health.
What is special about the company?
Novo Nordisk

πŸ“ˆ Want to read more about Novo Nordisk?

Sign up for free or log in

🎁 Free download! "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

MS4gRm9jdX Mgb24gZGlh YmV0ZXMgYW 5kIG90aGVy IGNocm9uaW MgZGlzZWFz ZXM6IE5vdm 8gTm9yZGlz ayBpcyBhIG dsb2JhbCBo ZWFsdGhjYX JlIGNvbXBh bnkgdGhhdC BzcGVjaWFs aXplcyBpbi Bwcm9kdWNp bmcgYW5kIG RldmVsb3Bp bmcgbWVkaW NhdGlvbnMg Zm9yIGRpYW JldGVzIGFu ZCBvdGhlci BjaHJvbmlj IGRpc2Vhc2 VzLCBzdWNo IGFzIG9iZX NpdHkgYW5k IHJhcmUgYm xvb2QgYW5k IGVuZG9jcm luZSBkaXNv cmRlcnMuIF RoaXMgZm9j dXMgYWxsb3 dzIHRoZW0g dG8gaGF2ZS BhIGRlZXAg dW5kZXJzdG FuZGluZyBv ZiB0aGVzZS BkaXNlYXNl cyBhbmQgcH JvdmlkZSBz cGVjaWFsaX plZCB0cmVh dG1lbnQgb3 B0aW9ucyBm b3IgcGF0aW VudHMuPGJy PjIuIFBpb2 5lZXJzIGlu IGluc3VsaW 4gcHJvZHVj dGlvbjogTm 92byBOb3Jk aXNrIHdhcy BvbmUgb2Yg dGhlIGZpcn N0IGNvbXBh bmllcyB0by BzdGFydCBw cm9kdWNpbm cgaW5zdWxp biwgYSBsaW ZlLXNhdmlu ZyBtZWRpY2 F0aW9uIGZv ciBwZW9wbG Ugd2l0aCBk aWFiZXRlcy 4gVGhleSBo YXZlIGJlZW 4gY29udGlu dW91c2x5IG ltcHJvdmlu ZyBhbmQgaW 5ub3ZhdGlu ZyB0aGVpci BpbnN1bGlu IHByb2R1Y3 RzIGZvciBv dmVyIDk1IH llYXJzLjxi cj4zLiBTdH JvbmcgY29t bWl0bWVudC B0byByZXNl YXJjaCBhbm QgZGV2ZWxv cG1lbnQ6IE 5vdm8gTm9y ZGlzayBpbn Zlc3RzIHNp Z25pZmljYW 50bHkgaW4g cmVzZWFyY2 ggYW5kIGRl dmVsb3BtZW 50IHRvIGlu bm92YXRlIG FuZCBpbXBy b3ZlIHRoZW lyIHByb2R1 Y3RzLiBUaG V5IGhhdmUg Y29sbGFib3 JhdGlvbnMg d2l0aCBsZW FkaW5nIHVu aXZlcnNpdG llcyBhbmQg cmVzZWFyY2 ggaW5zdGl0 dXRpb25zLC BhbmQgdGhl aXIgcmVzZW FyY2ggYW5k IGRldmVsb3 BtZW50IGVm Zm9ydHMgaG F2ZSByZXN1 bHRlZCBpbi B0aGUgZGV2 ZWxvcG1lbn Qgb2YgbWFu eSBpbm5vdm F0aXZlIHRy ZWF0bWVudH MuPGJyPjQu IFN1c3RhaW 5hYmxlIHBy YWN0aWNlcz ogTm92byBO b3JkaXNrIG lzIGNvbW1p dHRlZCB0by Bjb25kdWN0 aW5nIGJ1c2 luZXNzIGlu IGFuIGVudm lyb25tZW50 YWxseSBhbm Qgc29jaWFs bHkgcmVzcG 9uc2libGUg bWFubmVyLi BUaGV5IGhh dmUgc2V0IG FtYml0aW91 cyBnb2Fscy B0byByZWR1 Y2UgdGhlaX IgZW52aXJv bm1lbnRhbC BpbXBhY3Qs IHByb21vdG Ugc3VzdGFp bmFibGUgc2 91cmNpbmcs IGFuZCBpbX Byb3ZlIHRo ZWlyIHNvY2 lhbCBwZXJm b3JtYW5jZS 48YnI+NS4g UGF0aWVudC 1jZW50cmlj IGFwcHJvYW NoOiBOb3Zv IE5vcmRpc2 sgcHV0cyBw YXRpZW50cy BhdCB0aGUg Y2VudGVyIG 9mIHRoZWly IGJ1c2luZX NzLiBUaGV5 IHdvcmsgY2 xvc2VseSB3 aXRoIHBhdG llbnQgb3Jn YW5pemF0aW 9ucyB0byB1 bmRlcnN0YW 5kIHRoZSBu ZWVkcyBhbm QgY2hhbGxl bmdlcyBmYW NlZCBieSBw ZW9wbGUgbG l2aW5nIHdp dGggY2hyb2 5pYyBkaXNl YXNlcywgYW 5kIHVzZSB0 aGF0IGtub3 dsZWRnZSB0 byBkZXZlbG 9wIGltcGFj dGZ1bCBzb2 x1dGlvbnMu PGJyPjYuIE dsb2JhbCBy ZWFjaDogV2 l0aCBhIHBy ZXNlbmNlIG luIG1vcmUg dGhhbiAxNz AgY291bnRy aWVzLCBOb3 ZvIE5vcmRp c2sgcmVhY2 hlcyBhIGxh cmdlIG51bW JlciBvZiBw YXRpZW50cy Bhcm91bmQg dGhlIHdvcm xkLiBUaGV5 IGhhdmUgYS BzdHJvbmcg c2FsZXMgYW 5kIG1hcmtl dGluZyBuZX R3b3JrIGFu ZCBwYXJ0bm Vyc2hpcHMg d2l0aCBsb2 NhbCBvcmdh bml6YXRpb2 5zIHRvIGVu c3VyZSBhY2 Nlc3NpYmls aXR5IG9mIH RoZWlyIHBy b2R1Y3RzIH RvIHBhdGll bnRzIGdsb2 JhbGx5Ljxi cj43LiBDb3 Jwb3JhdGUg c29jaWFsIH Jlc3BvbnNp YmlsaXR5Oi BOb3ZvIE5v cmRpc2sgaG FzIGEgc3Ry b25nIGNvbW 1pdG1lbnQg dG8gbWFraW 5nIGEgcG9z aXRpdmUgaW 1wYWN0IGlu IHRoZSBjb2 1tdW5pdGll cyB0aGV5IG 9wZXJhdGUg aW4uIFRoZX kgaGF2ZSB2 YXJpb3VzIG luaXRpYXRp dmVzIHRvIG FkZHJlc3Mg aXNzdWVzIH N1Y2ggYXMg ZWR1Y2F0aW 9uLCBhY2Nl c3MgdG8gaG VhbHRoY2Fy ZSwgYW5kIG NvbW11bml0 eSBkZXZlbG 9wbWVudC48 YnI+OC4gRW 1wbG95ZWUg ZW5nYWdlbW VudCBhbmQg ZGV2ZWxvcG 1lbnQ6IFRo ZSBjb21wYW 55IHZhbHVl cyBpdHMgZW 1wbG95ZWVz IGFuZCBoYX MgYSB3b3Jr IGN1bHR1cm UgdGhhdCBw cm9tb3Rlcy BkaXZlcnNp dHksIGluY2 x1c2lvbiwg YW5kIGVtcG xveWVlIGRl dmVsb3BtZW 50LiBUaGV5 IG9mZmVyIH ZhcmlvdXMg dHJhaW5pbm cgYW5kIGRl dmVsb3BtZW 50IHByb2dy YW1zIGFuZC BlbmNvdXJh Z2UgYSBoZW FsdGh5IHdv cmstbGlmZS BiYWxhbmNl Ljxicj45Li BTdHJvbmcg ZmluYW5jaW FsIHBlcmZv cm1hbmNlOi BOb3ZvIE5v cmRpc2sgaG FzIGEgc29s aWQgZmluYW 5jaWFsIHBv c2l0aW9uLC B3aXRoIGNv bnNpc3Rlbn QgcmV2ZW51 ZSBhbmQgcH JvZml0IGdy b3d0aCBvdm VyIHRoZSB5 ZWFycy4gVG hpcyBlbmFi bGVzIHRoZW 0gdG8gcmVp bnZlc3QgaW 4gcmVzZWFy Y2ggYW5kIG RldmVsb3Bt ZW50IGFuZC BmdWxmaWxs IHRoZWlyIG NvbW1pdG1l bnRzIHRvd2 FyZHMgcGF0 aWVudHMgYW 5kIGNvbW11 bml0aWVzLj xicj4xMC4g QXdhcmRzIG FuZCByZWNv Z25pdGlvbj ogTm92byBO b3JkaXNrIG hhcyByZWNl aXZlZCBudW 1lcm91cyBh d2FyZHMgYW 5kIHJlY29n bml0aW9uIG ZvciB0aGVp ciBpbm5vdm F0aW9ucywg c3VzdGFpbm FiaWxpdHkg cHJhY3RpY2 VzLCBhbmQg ZW1wbG95ZW Ugc2F0aXNm YWN0aW9uLi BUaGlzIGZ1 cnRoZXIgaG lnaGxpZ2h0 cyB0aGVpci BkZWRpY2F0 aW9uIHRvIG 1ha2luZyBh IHBvc2l0aX ZlIGltcGFj dCBvbiBwYX RpZW50cywg ZW1wbG95ZW VzLCBhbmQg c29jaWV0eS 4=
What the company's business model?
Novo Nordisk

πŸ“ˆ Want to read more about Novo Nordisk?

Sign up for free or log in

πŸ“ Join us and grab your copy of "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

Tm92byBOb3 JkaXNrIGlz IGEgZ2xvYm FsIGhlYWx0 aGNhcmUgY2 9tcGFueSB0 aGF0IHNwZW NpYWxpemVz IGluIHRoZS Bwcm9kdWN0 aW9uIGFuZC BkZXZlbG9w bWVudCBvZi BwaGFybWFj ZXV0aWNhbC Bwcm9kdWN0 cyBhbmQgbW VkaWNhbCBk ZXZpY2VzLi BUaGVpciBi dXNpbmVzcy Btb2RlbCBm b2N1c2VzIG 9uIHRocmVl IG1haW4gYX JlYXM6IGRp YWJldGVzIG NhcmUsIG9i ZXNpdHksIG FuZCByYXJl IGJsb29kIG FuZCBlbmRv Y3JpbmUgZG lzb3JkZXJz Ljxicj4xLi BEaWFiZXRl cyBDYXJlOi BOb3ZvIE5v cmRpc2sgaX MgdGhlIG1h cmtldCBsZW FkZXIgaW4g ZGlhYmV0ZX MgY2FyZSwg cHJvdmlkaW 5nIGEgd2lk ZSByYW5nZS BvZiBwcm9k dWN0cyBmb3 IgdGhlIHRy ZWF0bWVudC BvZiBib3Ro IHR5cGUgMS BhbmQgdHlw ZSAyIGRpYW JldGVzLiBU aGlzIGluY2 x1ZGVzIGlu c3VsaW4sIG 9yYWwgYW50 aWRpYWJldG ljIGRydWdz LCBhbmQgZG V2aWNlcyBz dWNoIGFzIG luc3VsaW4g cGVucyBhbm QgcHVtcHMu IFRoZSBjb2 1wYW554oCZ cyBnb2FsIG lzIHRvIGlt cHJvdmUgdG hlIGxpdmVz IG9mIHBlb3 BsZSBsaXZp bmcgd2l0aC BkaWFiZXRl cyBieSBwcm 92aWRpbmcg aW5ub3ZhdG l2ZSBhbmQg ZWZmZWN0aX ZlIHRyZWF0 bWVudHMuPG JyPjIuIE9i ZXNpdHk6IE 5vdm8gTm9y ZGlzayBhbH NvIGhhcyBh IHN0cm9uZy Bmb2N1cyBv biBvYmVzaX R5LCBhIG1h am9yIHJpc2 sgZmFjdG9y IGZvciBkZX ZlbG9waW5n IHR5cGUgMi BkaWFiZXRl cy4gVGhlIG NvbXBhbnkg b2ZmZXJzIG EgcmFuZ2Ug b2YgbWVkaW NpbmVzIGFu ZCB3ZWlnaH QgbWFuYWdl bWVudCBwcm 9ncmFtcyB0 byBoZWxwIH Blb3BsZSB3 aXRoIG9iZX NpdHkgYWNo aWV2ZSBhbm QgbWFpbnRh aW4gYSBoZW FsdGh5IHdl aWdodC48Yn I+My4gUmFy ZSBCbG9vZC BhbmQgRW5k b2NyaW5lIE Rpc29yZGVy czogTm92by BOb3JkaXNr IGFsc28gaG FzIGEgYnVz aW5lc3Mgc2 VnbWVudCBk ZWRpY2F0ZW QgdG8gcmFy ZSBibG9vZC BhbmQgZW5k b2NyaW5lIG Rpc29yZGVy cyBzdWNoIG FzIGhlbW9w aGlsaWEsIG dyb3d0aCBo b3Jtb25lIG RlZmljaWVu Y3ksIGFuZC B0aHlyb2lk IGRpc29yZG Vycy4gVGhl eSBwcm92aW RlIHRyZWF0 bWVudHMgYW 5kIHN1cHBv cnQgZm9yIH BhdGllbnRz IGxpdmluZy B3aXRoIHRo ZXNlIHJhcm UgY29uZGl0 aW9ucy48Yn I+SW4gYWRk aXRpb24gdG 8gdGhlc2Ug bWFpbiBhcm VhcywgTm92 byBOb3JkaX NrIGFsc28g aGFzIGEgc3 Ryb25nIGVt cGhhc2lzIG 9uIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudCwgaW 52ZXN0aW5n IGEgc2lnbm lmaWNhbnQg cG9ydGlvbi BvZiB0aGVp ciByZXZlbn VlIGludG8g dGhlIGRldm Vsb3BtZW50 IG9mIG5ldy BhbmQgaW1w cm92ZWQgdH JlYXRtZW50 cyBmb3IgZG lhYmV0ZXMs IG9iZXNpdH ksIGFuZCBy YXJlIGRpc2 Vhc2VzLjxi cj5UaGVpci BidXNpbmVz cyBtb2RlbC BhbHNvIGlu Y2x1ZGVzIH BhcnRuZXJz aGlwcyBhbm QgY29sbGFi b3JhdGlvbn Mgd2l0aCBv dGhlciBwaG FybWFjZXV0 aWNhbCBjb2 1wYW5pZXMs IGhlYWx0aG NhcmUgcHJv dmlkZXJzLC BhbmQgcGF0 aWVudCBvcm dhbml6YXRp b25zIHRvIG Z1cnRoZXIg ZW5oYW5jZS B0aGVpciBw cm9kdWN0cy BhbmQgc2Vy dmljZXMuPG JyPk92ZXJh bGwsIE5vdm 8gTm9yZGlz a+KAmXMgYn VzaW5lc3Mg bW9kZWwgaX MgY2VudGVy ZWQgYXJvdW 5kIGltcHJv dmluZyB0aG UgbGl2ZXMg b2YgcGVvcG xlIHdpdGgg Y2hyb25pYy Bjb25kaXRp b25zLCB1dG lsaXppbmcg aW5ub3ZhdG l2ZSB0cmVh dG1lbnRzIG FuZCBwYXJ0 bmVyc2hpcH MgdG8gZHJp dmUgZ3Jvd3 RoIGFuZCBz dXN0YWluYW JpbGl0eS4=
Interesting facts about the company
Novo Nordisk

πŸ“ˆ Want to read more about Novo Nordisk?

Sign up for free or log in

πŸ“₯ Get our free eBook now: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvWj hqTTNkaElK M0ZjanFGRG NrTlUud2Vi cCIgYWx0PS JOb3ZvIE5v cmRpc2siIH RpdGxlPSJO b3ZvIE5vcm Rpc2siICBj bGFzcz0iaW 1nLWZsdWlk IiBoZWlnaH Q9OTAgd2lk dGg9OTAgbG 9hZGluZz0n bGF6eScgc3 R5bGU9J2Jv cmRlci1yYW RpdXM6IDZw eDsnPgoKIC AgICAgICAg ICAgICAgIC AgICA8ZGl2 IHN0eWxlPS dmbGV4OiAx OyB0ZXh0LW FsaWduOiBj ZW50ZXI7IG 1hcmdpbi1s ZWZ0OiA1cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPH Agc3R5bGU9 J2ZvbnQtc2 l6ZTogMjZw eDsgY29sb3 I6ICMzMzM7 IG1hcmdpbi 1ib3R0b206 IDE1cHg7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIP Cfk4ggV2Fu dCB0byByZW FkIG1vcmUg YWJvdXQgTm 92byBOb3Jk aXNrPwogIC AgICAgICAg ICAgICAgIC AgICAgICA8 L3A+CgogIC AgICAgICAg ICAgICAgIC AgICAgICA8 YSBocmVmPS dpbmRleC5w aHA/cGFnZT 1zaWdudXAn IHN0eWxlPS cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG JhY2tncm91 bmQtY29sb3 I6ICMwMDdC RkY7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBjb2xvcj ogI2ZmZjsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHBh ZGRpbmc6ID EwcHggMjBw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJvcmRlci 1yYWRpdXM6 IDVweDsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogbm 9uZTsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGZvbnQt d2VpZ2h0Oi Bib2xkOwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgbWFy Z2luLXJpZ2 h0OiAxMHB4 OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dHJhbnNpdG lvbjogYmFj a2dyb3VuZC 1jb2xvciAw LjNzIGVhc2 U7JwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Agb25tb3Vz ZW92ZXI9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A1NmIzIicK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIG9u bW91c2VvdX Q9J3RoaXMu c3R5bGUuYm Fja2dyb3Vu ZENvbG9yPS IjMDA3QkZG Iic+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBTaWduIH VwIGZvciBm cmVlCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv YT4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxz cGFuIHN0eW xlPSdtYXJn aW46IDAgOH B4OyBjb2xv cjogIzU1NT snPm9yPC9z cGFuPgoKIC AgICAgICAg ICAgICAgIC AgICAgICAg PGEgaHJlZj 0naW5kZXgu cGhwP3BhZ2 U9bG9naW4n IHN0eWxlPS cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG NvbG9yOiAj MDA3QkZGOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgdG V4dC1kZWNv cmF0aW9uOi B1bmRlcmxp bmU7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBmb250LX dlaWdodDog NTAwOyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBsb2 cgaW4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9hPgoKCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xwIHN0eWxl PSdtYXJnaW 4tdG9wOiAx NXB4OyBmb2 50LXNpemU6 IDEzcHg7IG ZvbnQtd2Vp Z2h0OiBib2 xkOyBjb2xv cjogI2QzMm YyZjsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAg4pyF IERvd25sb2 FkIDxpPiJU aGUgQ2hlY2 tsaXN0IFZh bHVlIEludm VzdG9yIOKA lCBBIFNtYX J0ZXIgV2F5 IHRvIFBpY2 sgU3RvY2tz IjwvaT4g4o CUIHRvdGFs bHkgZnJlZS EKICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9wPg oKICAgICAg ICAgICAgIC AgICAgICAg ICAgPCEtLQ ogICAgICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdt YXJnaW4tdG 9wOiAxMnB4 OyBmb250LX NpemU6IDEz cHg7IGNvbG 9yOiAjNDQ0 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBTaWduIH VwIG5vdyBh bmQgZ2V0IG 91ciBmcmVl IGVCb29rIA ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPG I+VGhlIENo ZWNrbGlzdC BWYWx1ZSBJ bnZlc3Rvci DigJQgQSBT bWFydGVyIF dheSB0byBQ aWNrIFN0b2 NrczwvYj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIC0tPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8IS0tCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xkaXYgc3R5 bGU9J21hcm dpbi10b3A6 IDE2cHg7IG ZvbnQtc2l6 ZTogMTRweD sgY29sb3I6 ICM0NDQ7IG ZvbnQtZmFt aWx5OiAtYX BwbGUtc3lz dGVtLCBCbG lua01hY1N5 c3RlbUZvbn QsIFNlZ29l IFVJLCBSb2 JvdG8sIEhl bHZldGljYS BOZXVlLCBz YW5zLXNlcm lmOyBsaW5l LWhlaWdodD ogMS42Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBI YXZlIHlvdS BoZWFyZCBh Ym91dCBvdX Igc2hvcnQg PHN0cm9uZy BzdHlsZT0n Zm9udC13ZW lnaHQ6IDYw MDsnPkRhaW x5IFZpZGVv IE5ld3NsZX R0ZXI8L3N0 cm9uZz4/Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICA8YS BocmVmPSdo dHRwczovL3 d3dy5pbnNp Z2h0ZnVsdm FsdWUuY29t L25ld3NsZX R0ZXIucGhw JyB0YXJnZX Q9J19ibGFu aycgc3R5bG U9J2NvbG9y OiAjMDA3Qk ZGOyB0ZXh0 LWRlY29yYX Rpb246IG5v bmU7IGZvbn Qtd2VpZ2h0 OiA1MDA7IG 1hcmdpbi1s ZWZ0OiA2cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBG aW5kIG91dC Btb3JlCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICAg ICAgICAgIC AgICAtLT4K ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgCi AgICAgICAg CiAgICAgIC AgPHNwYW4g Y2xhc3M9J2 JsdXJyZWQt dGV4dCc+Ci AgICAgICAg ICAgIE1TNG dUbTkyYnkg Qk9iM0prYV hOciBJR2x6 SUdFZ1oyIH h2WW1Gc0lH aGwgWVd4MG FHTmhjbSBV Z1kyOXRjR0 Z1IGVTQm9a V0ZrY1ggVm hjblJsY21W ayBJR2x1SU VKaFozIE4y dzZaeVpDd2 cgUkdWdWJX RnlheSA0Z1 NYUWdkMkZ6 IElHWnZkVz VrWlcgUWdh VzRnTVRreS BNeUJpZVNC QmRXIGQxYz NRZ1MzSnYg WjJnc0lFMW hjbSBsbElF dHliMmRvIE xDQklZVzV6 SUUgTm9jbW x6ZEdsaCBi aUJJWVdkbF pHIDl5Yml3 Z1lXNWsgSU VGMVozVnpk QyBCTGIyNW 5jM1JsIFpD NDhZbkkrTW kgNGdWR2hs SUdOdiBiWE JoYm5uaWdK IGx6SUcxaG FXNGcgWm05 amRYTWdhWC BNZ2IyNGdk R2hsIElHUm xkbVZzYjMg QnRaVzUwTE NCdyBjbTlr ZFdOMGFXID l1TENCaGJt UWcgYldGeW EyVjBhVyA1 bklHOW1JSE JvIFlYSnRZ V05sZFggUn BZMkZzSUcx bCBaR2xqWV hScGIyIDV6 TENCd1lYSj AgYVdOMWJH RnliSCBrZ2 FXNGdkR2hs IElHWnBaV3 hrSUcgOW1J R1JwWVdKbC BkR1Z6SUdO aGNtIFV1UE dKeVBqTXUg SUVsdUlERT VNaiBJc0lF NXZkbThnIF RtOXlaR2x6 YSsgS0FtWE 1nWm05MSBi bVJsY25Nc0 lFIEYxWjNW emRDQmggYm 1RZ1RXRnlh VyBVZ1MzSn ZaMmdzIElI ZGxjbVVnWV ggZGhjbVJs WkNCMCBhR1 VnVG05aVpX IHdnVUhKcG VtVWcgYVc0 Z1VHaDVjMi BsdmJHOW5l U0J2IGNpQk 5aV1JwWTIg bHVaU0JtYj NJZyBkR2hs YVhJZ1pHIG x6WTI5MlpY SjUgSUc5bU lHbHVjMyBW c2FXNGdZVz VrIElHbDBj eUJsWm0gWm xZM1FnYjI0 ZyBaR2xoWW 1WMFpYIE11 UEdKeVBqUX UgSUZSdlpH RjVMQyBCT2 IzWnZJRTV2 IGNtUnBjMn NnYVggTWdk R2hsSUhkdi BjbXhrNG9D WmN5IEJzWV hKblpYTjAg SUhCeWIyUj FZMiBWeUlH OW1JR2x1IG MzVnNhVzRz SUggZHBkR2 dnWVNCdCBZ WEpyWlhRZ2 MyIGhoY21V Z2IyWWcgWV hKdmRXNWtJ RCBVd0pTND hZbkkrIE5T NGdWR2hsSU cgTnZiWEJo Ym5rZyBhR0 Z6SUdFZ2NI IEpsYzJWdV kyVWcgYVc0 Z2IzWmxjaS BBNE1DQmpi M1Z1IGRISn BaWE1nWVcg NWtJR1Z0Y0 d4diBlWE1n Ylc5eVpTIE IwYUdGdUlE UTAgTERBd0 1DQndaVyA5 d2JHVWdaMn h2IFltRnNi SGt1UEcgSn lQall1SUU1 diBkbThnVG 05eVpHIGx6 YXlCcGN5Qm ogYjIxdGFY UjBaVyBRZ2 RHOGdjM1Z6 IGRHRnBibU ZpYVcgeHBk SGtnWVc1ay BJR2hoY3lC elpYIFFnWV NCbmIyRnMg SUhSdklHRm phRyBsbGRt VWdlbVZ5IG J5QmpZWEpp YjIgNGdaVz FwYzNOcCBi MjV6SUdKNU lEIEl3TXpB dVBHSnkgUG pjdUlFbHVJ RyBGa1pHbD BhVzl1IElI UnZJR1JwWV cgSmxkR1Z6 SUdOaCBjbV VzSUU1dmRt IDhnVG05eV pHbHogYXlC aGJITnZJRy BadlkzVnpa WE1nIGIyNG diM1JvWlgg SWdZMmh5Yj I1cCBZeUJo Ym1RZ2NtIE Z5WlNCa2FY TmwgWVhObG N5d2dhVyA1 amJIVmthVz VuIElHOWla WE5wZEgga3 NJR2hsYlc5 dyBhR2xzYV dFc0lHIGR5 YjNkMGFDQm sgYVhOdmNt UmxjbiBNc0 lHRnVaQ0Jv IGIzSnRiMj VsSUggSmxj R3hoWTJWdC BaVzUwSUhS b1pYIEpoY0 hrdVBHSnkg UGpndUlGUm 9aUyBCamIy MXdZVzU1IE lHbHVkbVZ6 ZEggTWdhR1 ZoZG1scyBl U0JwYmlCeV pYIE5sWVhK amFDQmggYm 1RZ1pHVjJa VyB4dmNHMW xiblFzIElI ZHBkR2dnWV ggSnZkVzVr SURJdyBKU0 J2WmlCcGRI IE1nWVc1dW RXRnMgSUhK bGRtVnVkVy BVZ1oyOXBi bWNnIGRHOT NZWEprY3kg QlNKa1F1UE dKeSBQamt1 SUU1dmRtID hnVG05eVpH bHogYXlCb1 lYTWdZUyBC emRISnZibW NnIFkyOXRi V2wwYlcgVn VkQ0IwYnlC eiBiMk5wWV d3Z2NtIFZ6 Y0c5dWMybG kgYVd4cGRI a2dZVyA1a0 lHaGhjeUJw IGJYQnNaVz FsYm4gUmxa Q0J6WlhabC BjbUZzSUds dWFYIFJwWV hScGRtVnog SUhSdklIQn liMyBacFpH VWdZV05qIF pYTnpJSFJ2 SUcgRm1abT l5WkdGaSBi R1VnYUdWaG JIIFJvWTJG eVpTQm0gYj NJZ2NHVnZj RyB4bElHbH VJRzVsIFpX UXNJSEJoY2 4gUnBZM1Zz WVhKcyBlU0 JwYmlCa1pY IFpsYkc5d2 FXNW4gSUdO dmRXNTBjbS BsbGN5NDhZ bkkrIE1UQX VJRWx1SUQg SXdNakFzSU hSbyBaU0Jq YjIxd1lXID U1SUhkaGN5 QnkgWVc1cl pXUWdibiBW dFltVnlJRz l1IFpTQnZi aUIwYUcgVW dRV05qWlhO eiBJSFJ2SU UxbFpHIGxq YVc1bElFbH UgWkdWNExD QjNhRyBsam FDQmxkbUZz IGRXRjBaWE 1nY0cgaGhj bTFoWTJWMS BkR2xqWVd3 Z1kyIDl0Y0 dGdWFXVnog NG9DWklHVm 1abSA5eWRI TWdkRzhnIG FXMXdjbTky WlMgQmhZMk 5sYzNNZyBk RzhnYldWa2 FXIE5wYm1V Z2FXNGcgYk c5M0lHRnVa QyBCdGFXUm tiR1V0IGFX NWpiMjFsSU cgTnZkVzUw Y21sbCBjeT Q9CiAgICAg ICAgPC9zcG FuPgogICAg ICAgIAogIC AgICAgIA==
See Company Q&A
Novo Nordisk

πŸ“Š Get full analytics about Novo Nordisk

Sign up for free or log in

πŸš€ Don’t miss "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal